Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
Tanzida Zubair et al, 2023, International Journal of Molecular Sciences CrossRef
Discovery of tetrandrine derivatives as tumor migration, invasion and angiogenesis inhibitors
Rong-Hong Zhang et al, 2020, Bioorganic Chemistry CrossRef
Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro
Yi‐Wen Jiang et al, 2019, Environmental Toxicology CrossRef
A vanillin derivative suppresses the growth of HT29 cells through the Wnt/β-catenin signaling pathway
Wantong Ma et al, 2019, European Journal of Pharmacology CrossRef
Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy
Yuan Liang et al, 2020, Pharmacological Research CrossRef
Anticancer activity oftetrandrineby inducing pro-death apoptosis and autophagy in human gastric cancer cells
Xin-Yu Bai et al, 2018, Journal of Pharmacy and Pharmacology CrossRef
Naturally Occurring Compounds as Potential Inhibitors of Epidermal Growth Factor Receptors (EGFRs)
Listiana Oktavia et al, 2023, Combinatorial Chemistry & High Throughput Screening CrossRef
Progress on structural modification of Tetrandrine with wide range of pharmacological activities
Liuying Mo et al, 2022, Frontiers in Pharmacology CrossRef
Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma
Junjie Lan et al, 2017, European Journal of Medicinal Chemistry CrossRef
Comparison of gene expression profiles of gingival carcinoma Ca9-22 cells and colorectal adenocarcinoma HT-29 cells to identify potentially important mediators of SLPI-induced cell migration
Tsuyoshi Takamura et al, 2017, Journal of Oral Science CrossRef
Integrated Network Pharmacology and Molecular Docking to Reveal the Mechanism of Tetrandrine in Tumor Chemoresistance
Xuehua Luo et al, 2021, Oncologie CrossRef